Industry Perspective:

The global enteral feeding formulas market size was worth USD 5,819.5 million in 2021 and is estimated to grow to USD 8,024.1 million by 2028, with a compound annual growth rate (CAGR) of 5.5% over the projected period. The report analyzes the enteral feeding formulas market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the enteral feeding formulas market.

Request Free Sample

Enteral Feeding Formulas Market: Overview

The term "enteral feeding" describes a procedure in which food is ingested through the GI system. The gastrointestinal tract comprises the stomach, esophagus, intestines, and mouth. The small intestine or stomach receives the nourishment that is ingested through a tube. This form of feeding can serve as the main nutrition source or a complete replacement for calories. In situations like cancer, eating difficulties, severe illness, stroke attacks, and life-threatening injuries, nutrition is considered. With an increase in the elderly population, increased occurrence of preterm birth, rising healthcare costs, and rising demand for in-home care, the global market for enteral feeding formula is expanding. The increased need for enteral nutrition formulae for older persons at home will also increase, which will spur market expansion. The sector is expanding because nursing homes and home health organizations choose enteral feeding formulae for post-surgery patients. Additionally, more neonatal critical care units are anticipated to fuel development. The development of the global enteral feeding formulas market is anticipated to be somewhat constrained by issues related to enteral nutrition, threats to patient safety, and the possibility of medication and feeding errors.

Request Free Sample

COVID-19 Impact:

As effective supportive care remains the cornerstone in managing critically ill patients with COVID-19 infection, nutritional management of the ICU admitted COVID-19 patients is an integral component of the supportive measures. As a result, the COVID-19 outbreak is anticipated to impact the market for enteral feeding formulas. The enteral feeding formula industry was accelerated by the increased demand for patients suffering from COVID-19 and related issues, and the market will support itself in the post-pandemic scenario.

Key Insights

• As per the analysis shared by our research analyst, the global enteral feeding formulas market value is expected to grow at a CAGR of 5.5% over the forecast period. 
• In terms of revenue, the global enteral feeding formulas market size was valued at around USD 5,819.5 million in 2021 and is projected to reach USD 8,024.1 million by 2028.
• The primary factors driving the global market for enteral feeding formulas are the escalating rate of preterm births, rising healthcare costs, escalating senior population, and expanding demand for homecare.
• With a share of 53.7% in the market in 2021, standard formulas dominated the product segment.
• Based on stage, the adult category had the highest revenue share of 88.6% in 2021.
• In 2021, North America's revenue share was 28.9%, which was the highest worldwide.

Enteral Feeding Formulas Market: Growth Drivers

The prevalence of chronic illnesses is driving market growth

The market for enteral feeding formulas is anticipated to rise as chronic diseases like cardiovascular disease, cancer, diabetes, and coronary obstructive pulmonary disorders (COPD) rise. These chronic illnesses necessitate a lengthier hospital stay and recovery period for treatment. Patients who have trouble swallowing food are given external nutrients through the tube. Thus, it is anticipated that an increase in the prevalence of chronic diseases will fuel global enteral feeding formula market expansion over the projected period. Additionally, the market for enteral feeding has seen a sharp rise in consumers due to the higher quality of the diet offered by tube feeding. Furthermore, as the number of senior citizens grows, so does the demand for tube feeding because these people are unable to eat orally.

Enteral Feeding Formulas Market: Restraints

The presence of allergic content in the product is expected to restraint the market growth

A wide variety of formulas are available for feeding during enteral procedures, and using a formula on someone who is not a good candidate for it can have negative side effects. Some patients must take formulae that are appropriate for their condition because they have allergies to specific proteins and fatty acids (food allergies from offenders including milk & lactose, maize, eggs, tree nuts, soy, wheat and gluten, seafood, and shellfish). Thus, choosing the best recipe is more difficult, which slows market expansion.

Enteral Feeding Formulas Market: Segmentation

The global enteral feeding formulas market has been segmented into product, stage, application, end user, and region.

Based on product, the worldwide enteral feeding formulas market is segmented into standard formulas and disease-specific formulas. Standard formulas dominated a share of 53.7% in the market in 2021. This significant market share can be due to standard formulae' widespread use and cost-effectiveness among all patient groups. Additionally, it is projected that the simple accessibility of polymeric nutritional complete formulae, which are appropriate for usage in both healthcare facilities and at home, will hasten segment growth over time.

Based on stage, the global enteral feeding formulas market is segmented into adults and pediatrics. The adult segment had the biggest revenue share at 88.6%. This market category is also predicted to expand in the upcoming years at the quickest CAGR. The significant market share can be due to the rising use of enteral tube feeding among individuals with a variety of illnesses, including chronic liver disease, multiple sclerosis, diabetes, cancer, and chronic obstructive pulmonary disease (COPD).

Based on application, the worldwide enteral feeding formulas market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. In the market for enteral feeding formulas, the oncology segment had a significant market share in 2021. Cancer cachexia, which causes insulin resistance, increased lipolysis with loss of body fat, accelerated protein turnover, and loss of muscle mass, as well as loss of appetite and weight, affects most cancer patients. Additionally, as it becomes exceedingly difficult for cancer patients to swallow food, supplying nourishment is essential for improving their clinical condition. Nutrition is given through enteral feeding tubes as the treatment progresses to help the patient keep their body mass.

The global enteral feeding formulas market is segmented based on end-users into hospitals and long-term care facilities. In 2021, the long-term care facilities had the most significant revenue share of 56.3%. The delivery of enteral nourishment to patients who need long-term, life-sustaining care outside of the hospital is expected to expand, which will hasten the growth of long-term care facilities. Another important aspect influencing the segment's growth is the fact that tube feeding is frequently the sole choice for people with chronic illnesses and disorders.

Recent Developments

• In September 2020, Victus, Inc. introduced "Abintra Care," specialized nutrition for daily immune support, which included a blend of important nutrients like vitamin C, antioxidants, zinc, and selenium. Additionally, it is fortified with 19g of protein overall, including whey protein and the conditionally necessary amino acids glutamine and arginine, which have been demonstrated to boost immune cell replication and protein synthesis.

Enteral Feeding Formulas Market: Regional Landscape

North America dominated the enteral feeding formulas market in 2021

North America held the largest share of the global enteral feeding formula market. The increased number of preterm births, growing geriatric population, and technological developments are to note for this dominance. Furthermore, the market growth in this region was fueled by high disposable income, an advanced healthcare system, the approval of new products, and increasing awareness. The enteral feeding formulae market is expanding rapidly, particularly in the United States. By 2060, it is anticipated that there will be more than twice as many Americans over the age of 65. The prevalence of chronic diseases like cancer and diabetes would rise as the geriatric population grew, lengthening patient stays in the hospital. Additionally, the WHO estimates that 15 million kids are born each year prematurely, and this number is still growing. As a result, during the course of the forecast, the market is anticipated to expand further in this area.

Report Scope:

Enteral Feeding Formulas Market: Competitive Landscape 

• Abbott Laboratories
• Nestlé S.A.
• Danone S.A.
• Mead Johnson Nutrition Company
• Fresenius Kabi AG
• Hormel Foods
• Global Health Product Inc.
• B. Braun Melsungen AG
• Meiji Holdings Co.
• Victus Inc.

Global Enteral Feeding Formulas Market is segmented as follows:

By Product

• Standard Formulas
• Disease-specific Formulas

By Stage

• Adults
• Pediatrics

By Application

• Oncology
• Gastroenterology
• Neurology
• Diabetes
• Critical Care
• Other Applications

By End User

• Hospitals
• Long-term Care Facilities

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa